Value Assessment Tools that take “Precision” out of “Precision Medicine” are Harmful to Patients

The conversation about health care costs is front and center in Washington, and new data on prescription drug spending has helped fuel this important debate. For example, we’ve recently learned national spending on retail drugs increased by only 1.3% in 2016, well below spending growth for hospitals (4.7 percent), physicians and clinical services (5.4 percent) and private health insurance (5.1 percent). We have also learned that changes in prescription drug prices are remarkably stable too